Diabetes News and Research

Latest Diabetes News and Research

Risk-adjusted TTR appears to improve anticoagulation control

Researchers from Boston University School of Medicine and the Bedford VA Medical Center believe that risk-adjusted percent time in therapeutic range should be used as part of an effort to improve anticoagulation control and thus improve patient outcomes.

4 Jan 2011

The Scientist examines how nonprofit, for-profit pharma groups are working together to make drugs more affordable for developing countries

"With philanthropists funneling billions of dollars into biomedical research and traditional drug discovery efforts producing fewer and fewer therapies, the line between for-profit and nonprofit life science companies is beginning to blur as both sides of the divide look for new options," The Scientist magazine writes in an article that examines the rise in collaborations between nonprofit pharmaceutical companies and for-profit groups.

4 Jan 2011

First whole genome sequence of Parsi breast cancer woman

Avesthagen Limited has yet again established its position as a leader in the successful application of next gen technologies as it announces the completion of the first Parsi breast cancer whole genome sequence of a 74-year-old Parsi woman with a heritable form of breast cancer. The incidence of breast cancer in most populations is strongly linked to a genetic basis but little is known about the variants at the present time.

4 Jan 2011

Fear of the fat promoted to curb obesity

The Australian Medical Association has recommended the use of graphic television advertisements in Victoria to warn people about the risks of eating fatty foods. Rising rates of obesity has prompted these extreme measures. The proposed ads in television and newspaper would cost $25 million and would show the effects of fat on the body’s internal organs. The AMA’s proposals are part of a submission calling for $63 million to fight obesity.

3 Jan 2011

Deceptive food labels lead to increased risk of deadly diseases

Did you know that when you pick up a product promoted as trans fat free, you may still be ingesting a significant amount of this potentially harmful substance? An article by Case Western Reserve University School of Medicine student Eric Brandt, published in the January/February 2011 issue of the American Journal of Health Promotion, reveals that misleading labeling practices can result in medically significant intake of harmful trans fat, despite what you read on Food and Drug Administration (FDA) approved labels.

3 Jan 2011

Flu worries continue

As number of cases of flu rise in the UK, Health Secretary Andrew Lansley is under pressure to strengthen the flu vaccination campaign. He reinstated a public health “Catch It, Bin It, Kill It” advertising campaign after he was warned by government advisers of the need to improve immunization rates which are at their lowest this winter for many years. It had been discontinued despite helping educate the public to adopt good hygiene habits during last year’s H1N1 swine flu epidemic at a cost of just £609,000. There were 12 more deaths in the last week from flu, bringing the total this winter to 39, the Health Protection Agency (HPA) said today. Thirty-six were killed by H1N1 swine flu, which is the most virulent of the two main flu strains currently circulating. The others died after contracting Influenza B, the other strain. All except one of the 39 were under 65 and four were under five.

2 Jan 2011

Mediterranean diet helps more than one chronic condition

In a study that was published in the Oct 13, 2001 issue of Diabetes Care, authors had reported that Mediterranean diet can reduce the risk of developing diabetes significantly. Those on this diet were 52 percent less likely to develop diabetes, compared with those who adhered least to the diet. Salas-Salvadó J. of Universitat Rovira i Virgili in Reus, Spain and colleagues compared two groups of subjects following two Mediterranean diets, one with nuts at 30 grams per day and the other with olive oil at 1 liter per week, with those on a low-fat diet.

2 Jan 2011

Team care to help multiple chronic conditions

According to a new study patients with multiple chronic diseases like diabetes mellitus and heart disease are at higher risk of depression that can render medication ineffective. Lead researcher Dr. Wayne J. Katon and colleagues at University of Washington in the study found that patients who received care from nurses who worked with patients and physicians to manage the care for depression and diabetes and heart disease had better outcomes. The study was published in the Dec 30, 2010 issue of New England Journal of Medicine.

2 Jan 2011

New Year resolution: Cosmetic dentistry

This New Year, we can make the same tired resolutions -- start exercising, eat better, stop smoking -- or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.

30 Dec 2010

Diamyd Medical publishes change in total number of votes and shares

As of December 30, 2010, the share capital in Diamyd Medical AB (publ.) is 14,736,117.50 SEK. The total number of votes is 4,241,311.9 and the total number of shares is 29,472,235, divided among 1,437,876 shares of series A (1 vote) and 28,034,359 shares of series B (1/10 vote).

30 Dec 2010

Low levels of microbe-killing molecules improve survival rate of people with CGD

Investigators at the National Institutes of Health have observed that the survival rate of people with a rare immunodeficiency disease called chronic granulomatous disease is greatly improved when even very low levels of microbe-killing molecules are present.

30 Dec 2010

Researchers to identify gene variants that cause ischemic stroke

Researchers from the University of Maryland School of Medicine are coordinating an international team of scientists working to identify genes or gene variants that may make a person more likely to have a particular type of stroke called an ischemic stroke.

30 Dec 2010

Centocor Ortho Biotech files REMICADE sBLA for ulcerative colitis in pediatric patients

Centocor Ortho Biotech Inc. announced today that it has filed a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) requesting the approval of REMICADE® (infliximab) for the treatment of moderately to severely active ulcerative colitis (UC) in pediatric patients who have had an inadequate response to conventional therapy.

29 Dec 2010

Experimental device for obstructive sleep apnea

Obstructive sleep apnea, a dangerous sleep disorder that affects millions of Americans may have found a cure. The disease commonly manifested as snoring but leading to tremendous sleep deprivation can be severely debilitating. Sleep deprivation may lead to car crashes, accidents, high blood pressure, heart attack, stroke, and diabetes.

29 Dec 2010

Florida Hospital, Sanford-Burnham and Takeda enter obesity research collaboration

Florida Hospital, Sanford-Burnham Medical Research Institute (Sanford-Burnham), and Takeda Pharmaceutical Company Limited (Takeda)(TSE: 4502), announced today that they have signed a research agreement to form a collaboration to discover and evaluate new therapeutic approaches to obesity, a growing worldwide health problem. The partnership aligns complementary strengths in biomedical research, clinical research and drug development to identify and validate obesity- related biomarkers and new peripheral molecular targets of mutual interest.

29 Dec 2010

Top weight-loss behaviors

Losing weight and saving money are the top New Year's resolutions expected to vex Americans this year, experts say.

29 Dec 2010

Researchers develop breath-analysis technology for rapid detection of biomarkers

Researchers have overcome a fundamental obstacle in developing breath-analysis technology to rapidly diagnose patients by detecting chemical compounds called "biomarkers" in a person's respiration in real time.

29 Dec 2010

Santarus, Pharming submit RHUCIN BLA to FDA for treatment of HAE attacks

Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) to obtain marketing approval for RHUCIN® (recombinant human C1 inhibitor) for the treatment of acute angioedema attacks in patients with Hereditary Angioedema (HAE).

29 Dec 2010

Exposure to persistent organic pollutants alters cortisol level in blood

Karin E Zimmer's PhD research shows that persistent organic pollutants (POPs), such as PCB and mixtures of different POPs, affect the way the adrenal cortex functions and thereby the synthesis of the stress hormone cortisol.

28 Dec 2010

Patients unresponsive to anti-anemia drug have higher risk of cardiovascular disease, death

Patients with diabetes, kidney disease and anemia who don't respond to treatment with an anti-anemia drug have a higher risk of cardiovascular disease or death, researchers at UT Southwestern Medical Center have found.

28 Dec 2010